A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

NCT03766581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2366

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke
Transient Ischemic Attack (TIA)

Interventions

DRUG: BMS-986177
OTHER: Placebo
DRUG: Clopidogrel
DRUG: Aspirin

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]